Bloodpressure clinical trials at UCSF

• Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD

  open to eligible people ages 16 years and up

  The transition from chronic kidney disease (CKD) to end-stage renal disease ESRD is a vulnerable and challenging period of time for patients and providers. Suboptimal control of blood pressure is known to be common in patients with the advanced stages of CKD, and may contribute to their elevated risk of progression to ESRD, cardiovascular morbidity, and mortality. This proposal is a pilot randomized controlled trial designed to test whether intensive blood pressure lowering is feasible and safe in patients with advanced CKD as they transition to ESRD.

  San Francisco, California

Last updated: August 25, 2020